Citations

Showing 10 of 108083 citations.

Prophylactic Cranial Irradiation for Extensive Small-Cell Lung Cancer
Daniels, T.B., Chun, Stephen G. , Rades, Dirk , Schild, Steven E. , Daniels, Thomas B, Sio, Terence T. , Chun, Stephen G

Mayo Clinic

Journal of Oncology Practice | November 10, 2017 | Volume: 13 | Issue: 11 | Pages: 732-738

10.1200/jop.2017.026765 | PMID 29125923 Get It

Small-cell lung cancer (SCLC) has a high predilection for metastasizing to the brain after chemotherapy. This has been blamed on the blood-brain barrier, which prevents chemotherapy from penetrating into the brain, thus creating a sanctuary site. It has been estimated that up to three quarters of patients with SCLC will eventually develop brain metastases. This led investigators to administer prophylactic cranial irradiation (PCI) to decrease this risk. Several trials were performed in patients with SCLC after initial therapy (chemotherapy with or without thoracic radiotherapy) that compared the outcomes of PCI versus no PCI. Early trials generally found that PCI significantly decreased the risk of brain metastases but did not significantly improve survival. These trials were re-evaluated in two larger meta-analyses that included patients with either limited-stage SCLC or extensive-stage SCLC (ESCLC). Both meta-analyses reported that PCI significantly decreased brain metastases and improved survival in patients who had a complete response following initial therapy. These studies were performed before the advent of modern imaging with computed tomography or magnetic resonance imaging (MRI). There have been two modern trials of PCI versus no PCI in patients with ESCLC and both found that PCI decreases brain metastases. The first did not include brain MRI before registration and found that PCI improved survival, whereas the second study did include MRI before registration and at frequent intervals thereafter. That trial found that PCI did not confer a survival advantage. This review will examine the evidence and provide recommendations regarding the role of PCI for patients with ESCLC.
Erratum. The addition of duraplasty to posterior fossa decompression in the surgical treatment of pediatric Chiari malformation Type I: a systematic review and meta-analysis of surgical and performance outcomes
Lu, Victor M.

Mayo Clinic

Journal of Neurosurgery: Pediatrics | November 10, 2017 | Volume: 21 | Issue: 2 | Pages: 197

10.3171/2017.10.peds16367a | PMID 29125448 Get It

Copper deposition in focal nodular hyperplasia and inflammatory hepatocellular adenoma
Chandan, Vishal S. , Shah, Sejal , Mounajjed, Taofic, Wu, Tsung‐Teh, Shah, Sejal S, Torbenson, Michael

Mayo Clinic

Journal of Clinical Pathology | November 10, 2017 | Volume: 71 | Issue: 6 | Pages: 504-507

10.1136/jclinpath-2017-204820 | PMID 29127141 Get It

Aims To examine copper deposition in focal nodular hyperplasia (FNH) and inflammatory hepatocellular adenoma (IHA) and to determine if it can play a role in their differentiation. Methods 28 FNHs and 19 IHAs from surgical resections showing typical morphological and immunohistochemical features were stained with rhodanine to evaluate for copper deposition. Histological features such as nodularity, fibrous bands, ductular proliferation, steatosis, ballooned hepatocytes and lymphocytic inflammation were also scored. Results Copper deposition was detected in 96% (27/28) of FNHs and 37% (7/19) of IHAs, P<0.001. In all cases, copper was seen within the hepatocytes only around the pseudo-portal tracts or areas of fibrosis. Copper deposition in IHA was significantly associated with presence of lymphocytic inflammation (P=0.04) but not associated with features like nodularity, fibrous bands, ductular proliferation, ballooned hepatocytes and steatosis (P>0.05, for all). In FNH, the presence and degree of copper deposition was not significantly associated with any histological features (P>0.05, for all). Conclusions Copper deposition occurs more frequently in FNH (96%) than IHA (37%), P<0.001. However, the presence of copper alone cannot be used as a feature to differentiate between FNH and IHA.
Gastrointestinal: Cystic endosalpingiosis of the spleen: CT, MR, and US imaging
McCullough, AE, Nguyen, Ba D.

Mayo Clinic

Journal of Gastroenterology and Hepatology | November 10, 2017 | Volume: 32 | Issue: 12 | Pages: 1911-1911

10.1111/jgh.13829 | PMID 29125210 Get It

Extracorporeal elimination of butalbital in acute aspirin–butalbital–caffeine–codeine (Fiorinal with Codeine) poisoning
Poyant, Janelle , Albright, Robert C. , Clain, Jeremy M., Pandompatam, Govind , Frazee, Erin N. , Poyant, Janelle O , Albright, Robert, Clain, Jeremy, Pandompatam, Govind

Mayo Clinic

Clinical Toxicology | November 10, 2017 | Volume: 56 | Issue: 6 | Pages: 439-441

10.1080/15563650.2017.1400554 | PMID 29124988 Get It

Mushrooms and the prevention and treatment of cancer.
Galena, A. E., Vaghefi, Simin B., Galena, A.E.

Mayo Clinic

Botanical medicine in clinical practice | November 10, 2017 | Volume: No volume available | Issue: No issue available | Pages: 293-300

10.1079/9781845934132.0293 Get It

Wingspan stent delivery catheter fracture and the TRAP technique for endovascular salvage
Jagani, Manoj, Heit, Jeremy J. , Heit, Jeremy J , M., Huy

Mayo Clinic

Interventional Neuroradiology | November 10, 2017 | Volume: 24 | Issue: 1 | Pages: 106-110

10.1177/1591019917737734 | PMID 29125024 Get It

Background Intracranial atherosclerotic disease may result in ischemic infarction and has a high rate of recurrent ischemic strokes despite medical therapy. Patients who fail medical therapy may undergo endovascular treatment with cerebral artery angioplasty and possible Wingspan stent placement. We present a unique case of Wingspan delivery microcatheter fracture that resulted in a retained foreign body and an endovascular salvage maneuver. Case description An elderly patient presented with an acute ischemic stroke due to a severe stenosis in the proximal left middle cerebral artery (MCA). The patient failed non-invasive medical treatment and underwent endovascular treatment with angioplasty and Wingspan stent placement. Following Wingspan stent deployment, the stent delivery catheter fractured, and the retained catheter fragment resulted in MCA occlusion. The foreign body was retrieved by balloon catheter inflation within an intermediate catheter adjacent to the proximal end of the fractured catheter and removal of the entire construct (TRAP technique). Conclusions Wingspan delivery microcatheter fracture is a rare event. The TRAP technique may be used for successful retrieval of a retained foreign body.
Retention of Interstitial Genes between TMPRSS2 and ERG Is Associated with Low-Risk Prostate Cancer
Kosari, Farhad , Karnes, R. Jeffrey , Nasir, Aqsa , Johnson, Sarah H. , Gaitatzes, Athanasios , Smadbeck, James B. , Rangel, Laureano J. , Vasmatzis, George , Cheville, John C. , Gaitatzes, Athanasios G, Murphy, Stephen J.

Mayo Clinic

Cancer Research | November 10, 2017 | Volume: 77 | Issue: 22 | Pages: 6157-6167

10.1158/0008-5472.can-17-0529 | PMID 29127096 Get It

Abstract TMPRSS2-ERG gene fusions occur in over 50% of prostate cancers, but their impact on clinical outcomes is not well understood. Retention of interstitial genes between TMPRSS2 and ERG has been reported to influence tumor progression in an animal model. In this study, we analyzed the status of TMPRSS2-ERG fusion genes and interstitial genes in tumors from a large cohort of men treated surgically for prostate cancer, associating alterations with biochemical progression. Through whole-genome mate pair sequencing, we mapped and classified rearrangements driving ETS family gene fusions in 133 cases of very low-, low-, intermediate-, and high-risk prostate cancer from radical prostatectomy specimens. TMPRSS2-ERG gene fusions were observed in 44% of cases, and over 90% of these fusions occurred in ERG exons 3 or 4. ERG fusions retaining interstitial sequences occurred more frequently in very low-risk tumors. These tumors also frequently displayed ERG gene fusions involving alternative 5′-partners to TMPRSS2, specifically SLC45A3 and NDRG1 and other ETS family genes, which retained interstitial TMPRSS2/ERG sequences. Lastly, tumors displaying TMPRSS2-ERG fusions that retained interstitial genes were less likely to be associated with biochemical recurrence (P = 0.028). Our results point to more favorable clinical outcomes in patients with ETS family fusion-positive prostate cancers, which retain potential tumor-suppressor genes in the interstitial regions between TMPRSS2 and ERG. Identifying these patients at biopsy might improve patient management, particularly with regard to active surveillance. Cancer Res; 77(22); 6157–67. ©2017 AACR.
Comparison of Inappropriate Shocks and Other Health Outcomes Between Single‐ and Dual‐Chamber Implantable Cardioverter‐Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Imp
Peterson, Pamela N., Greenlee, Robert T. , Go, Alan S. , Magid, David J. , Garcia‐Montilla, Romel , Glenn, Karen A., Gurwitz, Jerry H. , Hammill, Stephen C., Hayes, John, Kadish, Alan H. , Sharma, Param , Smith, David H. , Varosy, Paul D. , Vidaillet, Humberto, Zeng, Chan , Masoudi, Frederick A. , Peterson, Pamela N. , Cassidy‐Bushrow, Andrea E. , Reynolds, Kristi , Normand, Sharon‐Lise T.

Mayo Clinic

Journal of the American Heart Association | November 10, 2017 | Volume: 6 | Issue: 11 | Pages: No page available

10.1161/jaha.117.006937 | PMID 29122811 Get It

Background In US clinical practice, many patients who undergo placement of an implantable cardioverter‐defibrillator ( ICD ) for primary prevention of sudden cardiac death receive dual‐chamber devices. The superiority of dual‐chamber over single‐chamber devices in reducing the risk of inappropriate ICD shocks in clinical practice has not been established. The objective of this study was to compare risk of adverse outcomes, including inappropriate shocks, between single‐ and dual‐chamber ICD s for primary prevention. Methods and Results We identified patients receiving a single‐ or dual‐chamber ICD for primary prevention who did not have an indication for pacing from 15 hospitals within 7 integrated health delivery systems in the Longitudinal Study of Implantable Cardioverter‐Defibrillators from 2006 to 2009. The primary outcome was time to first inappropriate shock. ICD shocks were adjudicated for appropriateness. Other outcomes included all‐cause hospitalization, heart failure hospitalization, and death. Patient, clinician, and hospital‐level factors were accounted for using propensity score weighting methods. Among 1042 patients without pacing indications, 54.0% (n=563) received a single‐chamber device and 46.0% (n=479) received a dual‐chamber device. In a propensity‐weighted analysis, device type was not significantly associated with inappropriate shock (hazard ratio, 0.91; 95% confidence interval, 0.59–1.38 [ P =0.65]), all‐cause hospitalization (hazard ratio, 1.03; 95% confidence interval, 0.87–1.21 [ P =0.76]), heart failure hospitalization (hazard ratio, 0.93; 95% confidence interval, 0.72–1.21 [ P =0.59]), or death (hazard ratio, 1.19; 95% confidence interval, 0.93–1.53 [ P =0.17]). Conclusions Among patients who received an ICD for primary prevention without indications for pacing, dual‐chamber devices were not associated with lower risk of inappropriate shock or differences in hospitalization or death compared with single‐chamber devices. This study does not justify the use of dual‐chamber devices to minimize inappropriate shocks.